Send to printer »

GEN News Highlights : Aug 31, 2009

Novartis to Exploit Nuevolution Platform for Drug Discovery

Novartis enlisted the help of Danish drug discovery company Nuevolution to identify small molecule leads against specific drug targets. Nuevolution will use its fragment-based drug screening platform called ChemeticsĀ®. The company says this technology combines proven wet chemistry and molecular biology to allow the rapid synthesis and selection of ligands from potentially billions of drug-like compounds in a single test tube.  The companies will work together to carry out hit-to-lead optimization.